Christopher Sorli
Technik-/Wissenschafts-/F&E-Leiter bei ACERUS PHARMACEUTICALS CORPORATION
Aktive Positionen von Christopher Sorli
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACERUS PHARMACEUTICALS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 17.07.2020 | - |
Karriereverlauf von Christopher Sorli
Ehemalige bekannte Positionen von Christopher Sorli
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Sanofi SA | Corporate Officer/Principal | 01.11.2019 | 01.07.2020 |
Statistik
International
| Kanada | 2 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
| Sanofi SA | Health Technology |
- Börse
- Insiders
- Christopher Sorli
- Erfahrung
